SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial

NCT05138575 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: Empagliflozin + Potassium Chloride
DRUG: Empagliflozin + Potassium Nitrate
DRUG: Potassium Chloride + Placebo for Empagliflozin

Sponsor

University of Pennsylvania